HIF1A and cancer: Taken together, studies we discuss here show that, even though PHD-mediated hydroxylation of HIF-1α seems an impeccable mechanism to control its stability, many novel regulators of HIF-1α are emerging, especially in the context of cancer, where the selective pressures to activate this protumorigenic protein are particularly strong.